Related Experiment Video

Updated: Jul 15, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells

JoAnn M Gensert1, Oxana V Baranova, David E Weinstein

  • 1The Winifred Masterson Burke/Cornell Medical Research Institute, 785 Mamaroneck Ave., White Plains, NY 10605, USA. jg85@columbia.edu

Neurobiology of Disease
|May 8, 2007
PubMed

Insights

Histone deacetylase inhibitors (HDACi) induce growth arrest in glioma cells by increasing CD81 expression. This novel strategy targets epigenetically silenced genes, offering a new approach for glioma treatment.

Area of Science:

  • Cancer Cell Biology
  • Epigenetics
  • Neuro-oncology

Background:

  • Histone deacetylase inhibitors (HDACi) target critical cancer pathways.
  • HDACi can re-activate epigenetically silenced genes, promoting anti-cancer effects.
  • CD81, a tetraspanin, is a repressed gene in glioma cells that regulates cytostasis.

Purpose of the Study:

  • To investigate the role of HDAC inhibitors in modulating CD81 expression in glioma cells.
  • To determine if HDAC inhibition-induced CD81 expression contributes to cytostasis in glioma.
  • To explore a novel therapeutic strategy for glioma treatment.

Main Methods:

  • Treatment of glioma cells with HDAC inhibitors (trichostatin, sodium butyrate).
  • Assessment of cell growth arrest, differentiation, and cell death.
  • Analysis of CD81 and p21(CIP/WAF-1) gene expression.
  • RNA interference (RNAi) knock-down of CD81 to assess its role in cytostasis.

Main Results:

  • HDAC inhibitors promoted growth arrest and differentiation in glioma cells with minimal cell death.
  • HDAC inhibitors induced the expression of CD81 and p21(CIP/WAF-1).
  • CD81 knock-down abrogated the cytostatic effects of HDAC inhibition, confirming CD81's critical role.

Conclusions:

  • HDAC inhibition is a viable strategy to induce CD81 expression in glioma cells.
  • HDACi-induced CD81 expression is responsible for mediating growth arrest.
  • Targeting CD81 via HDAC inhibition represents a novel therapeutic approach for glioma.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...